{"schema_version":"1","generated_at":"2026-10-30T07:06:11.827Z","data_as_of":null,"url":"https://www.findmykol.com/kol/steven-waggoner","json_url":"https://www.findmykol.com/kol/steven-waggoner/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"steven-waggoner","name":"Steven Waggoner","credential":"MD","specialty":"Gynecologic Oncology","specialty_raw":"Gynecologic Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Cleveland Clinic","institution_url":"https://www.findmykol.com/institution/cleveland-clinic","city":"Cleveland","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1851322150","orcid":"0000-0001-7037-4858","openalex":"A5044100563"},"summary":"Steven Waggoner is an Oncology physician affiliated with Cleveland Clinic. OpenAlex indexes 278 publications with 7,999 citations (h-index 44); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":278,"cited_by_count":7999,"h_index":44,"latest_activity_year":2025,"emerging":true,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT01652794","title":"Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"Case Comprehensive Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT01652794","trial_url":"https://www.findmykol.com/trial/NCT01652794"},{"nct":"NCT00096200","title":"Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT00096200","trial_url":"https://www.findmykol.com/trial/NCT00096200"}],"source":"trials"},"payments":{"company_count":9,"program_years":{"first":2021,"last":null},"rows_total":9,"shown":3,"withheld":6,"rows":[{"payer":"CooperSurgical, Inc.","program_year":2025,"amount_usd":59.98,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1851322150"},{"payer":"Genmab U.S., Inc.","program_year":2025,"amount_usd":34.85,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1851322150"},{"payer":"Janssen Biotech, Inc.","program_year":2025,"amount_usd":18.23,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1851322150"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1851322150","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis","year":2021,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2021.06.017","status":"verified"},{"title":"Randomized phase II study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (R-MPV-A) with and without low-dose whole-brain radiotherapy (LD-WBRT) for newly diagnosed primary CNS lymphoma (PCNSL).","year":2020,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.2501","status":"verified"},{"title":"A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer.","year":2020,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.6003","status":"verified"},{"title":"Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma","year":2019,"journal":"JAMA Oncology","source_url":"https://doi.org/10.1001/jamaoncol.2019.1048","status":"verified"},{"title":"Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial","year":2019,"journal":"The Lancet Oncology","source_url":"https://doi.org/10.1016/s1470-2045(19)30178-0","status":"verified"}],"source":"works"},"contact":{"address_1":"11100 EUCLID AVE","city":"Cleveland","state":"OH","zip":"441061716","phone":"216-844-3941","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1851322150","source":"identity"},"similar":[{"name":"Steven Nissen","slug":"steven-nissen","institution":"Cleveland Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/steven-nissen","json_url":"https://www.findmykol.com/kol/steven-nissen/profile.json"},{"name":"Samir Kapadia","slug":"samir-kapadia","institution":"Cleveland Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/samir-kapadia","json_url":"https://www.findmykol.com/kol/samir-kapadia/profile.json"},{"name":"Mina Chung","slug":"mina-chung","institution":"Cleveland Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/mina-chung","json_url":"https://www.findmykol.com/kol/mina-chung/profile.json"},{"name":"Serpil Erzurum","slug":"serpil-erzurum","institution":"Cleveland Clinic","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/serpil-erzurum","json_url":"https://www.findmykol.com/kol/serpil-erzurum/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":6,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2020-11-22","provider_certified":"2020-11-22","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}